During the past decade, Long Beach Center for Clinical Research conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 36 clinical trials were completed, i.e. on average, 76.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 30 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Long Beach Center for Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Long Beach Center for Clinical Research" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Integrium" with 3 trials as a collaborator, "bioRASI, LLC" with 3 trials as a collaborator, "Great Lakes Drug Development, Inc." with 2 trials as a collaborator and "Novum Pharmaceutical Research Services" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Long Beach Center for Clinical Research" are "Diabetes Mellitus, Type 2" (7 trials), "COVID-19" (5 trials), "Hypertension" (5 trials), "Asthma" (4 trials) and "Low Back Pain" (3 trials). Many other conditions were trialed in "Long Beach Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Long Beach Center for Clinical Research" are "Drug" (59 trials), "Biological" (9 trials), "Other" (8 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "placebo" (3 trials), "Atogepant" (2 trials), "BMS-986165" (2 trials) and "Daridorexant 25 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Long Beach Center for Clinical Research" are 66 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Long Beach Center for Clinical Research". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Long Beach Center for Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Long Beach Center for Clinical Research, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".